This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Becker, Michael
| Item Type | Name |
|
Concept
|
Gout Suppressants
|
|
Academic Article
|
Update on emerging urate-lowering therapies.
|
|
Academic Article
|
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
|
|
Academic Article
|
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
|
|
Academic Article
|
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
|
|
Academic Article
|
Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.
|
|
Academic Article
|
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
|
|
Academic Article
|
What do I need to know about gout?
|
|
Academic Article
|
Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities.
|
|
Academic Article
|
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.
|
|
Academic Article
|
Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
|
|
Academic Article
|
Quality of life and disability in patients with treatment-failure gout.
|
|
Academic Article
|
Patient-reported outcomes in chronic gout: a report from OMERACT 10.
|
|
Academic Article
|
Treating hyperuricemia of gout: safety and efficacy of febuxostat and allopurinol in older versus younger subjects.
|
|
Academic Article
|
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy.
|
|
Academic Article
|
Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials.
|
|
Academic Article
|
Diabetes and gout: efficacy and safety of febuxostat and allopurinol.
|
|
Academic Article
|
Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy.
|
|
Academic Article
|
Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.
|
|
Academic Article
|
Long-term management of gout: nonpharmacologic and pharmacologic therapies.
|
|
Academic Article
|
Long-term safety of pegloticase in chronic gout refractory to conventional treatment.
|
|
Academic Article
|
An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
|
|
Academic Article
|
Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.
|
|
Academic Article
|
Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
|
|
Academic Article
|
Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study.
|
|
Academic Article
|
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.
|
|
Academic Article
|
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
|
|
Academic Article
|
Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study.
|
|
Academic Article
|
Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial.
|